A model-based selection approach to identify suitable indications for proton therapy
Update: 2017-08-09
Description
Prof Langendijk speaks with ecancertv at Proton Therapy Congress 2016 about patient selection for proton therapy.
Considering the altered toxicity profile and costs associated with proton beam therapy (PBT) compared to current radiotherapy techniques, he describes planning a pair of therapeutic options based on modelling of expected patient response for external beam or proton therapy.
Overall, Prof Langendijk rates the cost effectiveness of PBT as potentially beneficial in some patients, and encourages further randomised trials of novel technologies.
Considering the altered toxicity profile and costs associated with proton beam therapy (PBT) compared to current radiotherapy techniques, he describes planning a pair of therapeutic options based on modelling of expected patient response for external beam or proton therapy.
Overall, Prof Langendijk rates the cost effectiveness of PBT as potentially beneficial in some patients, and encourages further randomised trials of novel technologies.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
